Direct current cardioversion for symptomatic atrial fibrillation or flutter is feasible and safe in patients implanted with the Watchman left atrial appendage (LAA) occlusion device, even in the ...
A Food and Drug Administration (FDA) advisory committee has voted 11 to 2 against a recommendation that the agency approve a long-studied antiarrhythmic agent for cardioversion of recent-onset atrial ...
ATRIAL fibrillation is one of the most prevalent of the chronic rhythm disorders of the heart. It is a derangement with serious implications. Even when the patient is asymptomatic the arrhythmia is by ...
New York, NY - The use of transesophageal echocardiography (TEE) to guide cardioversion in patients with atrial fibrillation (AF) has taken a step closer to being accepted into medical practice, ...
VANCOUVER, June 12, 2015 /CNW/ - Cardiome Pharma Corp. (NASDAQ: CRME /TSX: COM) today announced that an independent study conducted by investigators at the University of Leipzig Heart Center, Germany, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback